date:Jan 22, 2013
The global market for industrial enzymes grew by an estimated 7% to DKK 21 billion in 2012. Novozymes retained its market share at 47%.
BioBusiness sales were DKK 1,071 million, up by 5% compared with 2011. Sales in local currency were flat compared with 2011. BioBusiness sales grew by 10% organically, adjusting for the divestment impact of Novozymes Biopharma operations in Sweden in 2011 and the acquisition impact of EMD/Merck Crop BioScience.
Household care enzymes sales increased by 14% i